However when comparing patients of group 1 to all patients with NB harbouring MYCN amplification, i.e. groups 2 and 3 pooled together, we found a significantly better OS for group 1 (Figure 2C, P = 0, 045). The gene discussed is MYCN; the disease is neuroblastoma.